HK1076037A1 - Use of collagenase to facilitate guide wire crossing in total arterial occlusions - Google Patents

Use of collagenase to facilitate guide wire crossing in total arterial occlusions

Info

Publication number
HK1076037A1
HK1076037A1 HK05108158A HK05108158A HK1076037A1 HK 1076037 A1 HK1076037 A1 HK 1076037A1 HK 05108158 A HK05108158 A HK 05108158A HK 05108158 A HK05108158 A HK 05108158A HK 1076037 A1 HK1076037 A1 HK 1076037A1
Authority
HK
Hong Kong
Prior art keywords
collagenase
guide wire
wire crossing
arterial occlusions
total arterial
Prior art date
Application number
HK05108158A
Other languages
English (en)
Inventor
Bradley H Strauss
Original Assignee
Bradley H Strauss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bradley H Strauss filed Critical Bradley H Strauss
Publication of HK1076037A1 publication Critical patent/HK1076037A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05108158A 2001-10-01 2005-09-16 Use of collagenase to facilitate guide wire crossing in total arterial occlusions HK1076037A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32553901P 2001-10-01 2001-10-01
PCT/CA2002/001476 WO2003028756A2 (en) 2001-10-01 2002-10-01 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions

Publications (1)

Publication Number Publication Date
HK1076037A1 true HK1076037A1 (en) 2006-01-06

Family

ID=23268311

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108158A HK1076037A1 (en) 2001-10-01 2005-09-16 Use of collagenase to facilitate guide wire crossing in total arterial occlusions

Country Status (13)

Country Link
US (3) US20050053548A1 (xx)
EP (1) EP1438065B1 (xx)
JP (1) JP2005503820A (xx)
CN (1) CN1327893C (xx)
AU (1) AU2002328729C1 (xx)
CA (1) CA2462512C (xx)
DK (1) DK1438065T3 (xx)
ES (1) ES2396964T3 (xx)
HK (1) HK1076037A1 (xx)
IL (2) IL161137A0 (xx)
PT (1) PT1438065E (xx)
SI (1) SI1438065T1 (xx)
WO (1) WO2003028756A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525048A (ja) * 2000-03-02 2003-08-26 インサイト・ゲノミックス・インコーポレイテッド 脂質代謝酵素
US6569129B1 (en) * 2000-09-13 2003-05-27 Mayo Foundation For Medical Education And Research Biological revascularization
ES2396964T3 (es) * 2001-10-01 2013-03-01 Matrizyme Pharma Corporation Uso de colagenasa para facilitar el cruce con alambre de guia de oclusiones arteriales crónicas
WO2005097177A1 (en) * 2004-04-08 2005-10-20 Strauss Bradley H Use of collagenase to facilitate guide wire crossing in total arterial occlusions
JP2008521523A (ja) * 2004-12-02 2008-06-26 ブラッドリー・エイチ・ストラウス 慢性完全閉塞部におけるガイドワイヤーの通過を容易にし、促進するための管腔内微細血管形成の増強
JP2007181413A (ja) * 2006-01-05 2007-07-19 Fujifilm Corp 血管壁障害モデル動物の作成方法
US20070184083A1 (en) * 2006-02-07 2007-08-09 Medtronic Vascular, Inc. Drug-Eluting Device for Treatment of Chronic Total Occlusions
US8541370B2 (en) 2007-02-26 2013-09-24 Proyecto De Biomedicina Cima, S.L. Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments
ES2335167B1 (es) * 2007-02-26 2011-01-24 Proyecto De Biomedicina Cima, S.L. Uso de la metaloproteinasa de matriz-10 (mmp10) para tratamientos tromboliticos.
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US8016799B2 (en) * 2008-04-22 2011-09-13 Medtronic Vascular, Inc. Catheter having a detachable tip
WO2011130537A2 (en) * 2010-04-14 2011-10-20 Northwestern University Pharmaceutical compositions and methods for digesting atherosclerotic plaques
US20120259314A1 (en) * 2011-04-11 2012-10-11 Medtronic Vascular, Inc. Apparatus and Methods for Recanalization of a Chronic Total Occlusion
CN103157099B (zh) * 2011-12-19 2015-03-18 吴宗贵 一种用于血管外膜快速消化的混合酶消液及其制备方法
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
WO2014134532A1 (en) * 2013-02-28 2014-09-04 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
CN103340663B (zh) * 2013-06-17 2016-05-04 李宝童 囊式冠脉压迫装置及慢性心肌缺血动物模型制造方法
CN110248695B (zh) * 2016-12-15 2024-03-12 卢塞德血管有限公司 用于治疗血管相关疾病的方法及装置
US20220265291A9 (en) * 2018-06-28 2022-08-25 Marizyme, Inc. Pharmaceutical compositions and methods for the treatment of thrombosis and delivery by medical devices
WO2020006444A1 (en) * 2018-06-28 2020-01-02 Marizyme Biotech Pharmaceutical compositions and methods for the treatment of thrombosis and delivery by medical devices
CN115245143A (zh) * 2022-07-06 2022-10-28 上海市中西医结合医院 一种动脉闭塞性疾病动物模型的构建方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636195A (en) * 1982-04-02 1987-01-13 Harvey Wolinsky Method and apparatus for removing arterial constriction
US6025477A (en) 1986-03-31 2000-02-15 Calenoff; Emanuel Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5955584A (en) * 1986-03-31 1999-09-21 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5811248A (en) 1986-03-31 1998-09-22 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
US5163421A (en) * 1988-01-22 1992-11-17 Angiosonics, Inc. In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging
US5024829A (en) * 1988-11-21 1991-06-18 Centocor, Inc. Method of imaging coronary thrombi
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
DK0472657T3 (da) * 1989-05-17 1996-06-17 Res Corp Technologies Inc Fremgangsmåde og middel til behandling af trombose i et pattedyr
US5422261A (en) * 1993-04-16 1995-06-06 Baxter International Inc. Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells
US5613949A (en) * 1994-04-01 1997-03-25 Advanced Cardiovascular Systems, Inc. Double balloon catheter assembly
US5540637A (en) 1995-01-25 1996-07-30 Ccs, Llc Stationary exercise apparatus having a preferred foot platform orientation
US6020181A (en) 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US6306166B1 (en) * 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
EP0920882A3 (en) 1997-12-04 2000-01-05 Schneider Inc. Balloon dilatation-drug delivery catheter and stent deployment-drug delivery catheter in rapid exchange configuration
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6569129B1 (en) * 2000-09-13 2003-05-27 Mayo Foundation For Medical Education And Research Biological revascularization
US6623452B2 (en) * 2000-12-19 2003-09-23 Scimed Life Systems, Inc. Drug delivery catheter having a highly compliant balloon with infusion holes
US6780849B2 (en) * 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US6808518B2 (en) * 2001-09-28 2004-10-26 Ethicon, Inc. Methods and devices for treating diseased blood vessels
ES2396964T3 (es) * 2001-10-01 2013-03-01 Matrizyme Pharma Corporation Uso de colagenasa para facilitar el cruce con alambre de guia de oclusiones arteriales crónicas

Also Published As

Publication number Publication date
WO2003028756A2 (en) 2003-04-10
EP1438065A2 (en) 2004-07-21
US20050053548A1 (en) 2005-03-10
AU2002328729C1 (en) 2009-11-26
US7425326B2 (en) 2008-09-16
CA2462512A1 (en) 2003-04-10
IL161137A0 (en) 2004-08-31
JP2005503820A (ja) 2005-02-10
CN1327893C (zh) 2007-07-25
CA2462512C (en) 2013-11-05
SI1438065T1 (sl) 2013-03-29
ES2396964T3 (es) 2013-03-01
PT1438065E (pt) 2013-01-24
AU2002328729B2 (en) 2009-07-16
CN1599621A (zh) 2005-03-23
IL161137A (en) 2014-08-31
US8021660B2 (en) 2011-09-20
US20070014783A1 (en) 2007-01-18
EP1438065B1 (en) 2012-11-21
AU2002328729A2 (en) 2003-04-14
US20090074744A1 (en) 2009-03-19
DK1438065T3 (da) 2013-02-11
WO2003028756A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
HK1076037A1 (en) Use of collagenase to facilitate guide wire crossing in total arterial occlusions
AU2003291032A8 (en) Guide wire control catheters for crossing occlusions and related methods of use
HK1061403A1 (en) ANTIBODIES TO HUMAN IL-1ß
DE10192161T1 (de) Medizinischer Führungsdraht
IL153721A0 (en) Antibodies to human mcp-1
GB2365353B (en) Active arterial embolization filter
HUP0402162A3 (en) Specific binding agents of human angiopoietin-2
PL377590A1 (pl) Nowe zastosowanie erytropoetyny w chorobach serca
HK1050013A1 (zh) 抗人IL-1β抗體
DE60231004D1 (de) Führungskatheter
NO20031129L (no) Human koagulasjonsfaktor VII-varianter
DE60221143D1 (de) Brusteinlage enthaltend hautpflegemittel
NO20041802L (no) Antistoffer mot human vevsfaktor
EP1388053A4 (en) OUTPUT AND PERFORMANCE OF STORAGE INSTRUCTIONS FOR AVOIDING READ-WRITE HAZARDS
HUP0401903A3 (en) Improved use of et-743 in cancer thereapy
DE50115522D1 (de) Strangführungssegment
EP1293131A4 (en) THERAPEUTIC AGENTS FOR THE THROAT
AU7193001A (en) Methods of enhancing delivery of oil-soluble skin care actives
DE60031798D1 (de) Führungsdraht aus verbundstoff
IL144963A0 (en) Index of businesses-according to their time of activity
TW414007U (en) Structure of water-dripping irrigator
IL161441A0 (en) Pathway of rantes-mediated chemokine synthesis in astrocytes and method of use therefor
MA25701A1 (fr) Solution pour ameliorer et organiser les operations des pelerins
TW493637U (en) Drainage head structure used in worktop
FI20020213A0 (fi) Betaiinin käyttö hiustenhoidossa

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211001